Menu
EXECUTIVE LEADERSHIP & SCIENTIFIC ADVISORY BOARD
Avologi is a luxurious medical beauty brand founded in 2012 by engineers from the Technion Institute, collaborating with world-renowned Nobel Prize Lurates. Captivating new intelligence in medical beauty solutions and architects of high-tech, Avologi is derived from professional medical and aesthetic treatments, enabling consumers to achieve professional results at home.
Professor Barry Barish
2017 Nobel prize laureate in physics on the laser interferometer gravitational wave observatory.
Chair in Physics at Stony Brook University
Yaniv Yuval, BSC
Magna cum laude EE engineering graduate; 2018 Global beauty award winner Technion University
Zvia Hashaiev, RN, BSN, BA, CBC
Plastic surgery and aesthetics specialist Sourasky Medical Center – Ichilov Hospital
Randy Schekman, PhD
HHII Professor of Cell and Developmental Biology; 2013 Nobel Laureate in Physiology or Medicine
Berkeley University Of California
Professor Barry Barish is an American experimental physicist and Nobel Laureate. He is a Linde Professor of Physics, emeritus at California Institute of Technology and a leading expert on gravitational waves.
In 2017, Barish was awarded the Nobel Prize in Physics for his work on the laser interferometer gravitational wave observatory. He said: “I didn’t know if I would succeed. I was afraid I would fail, but because I tried, I had a breakthrough.”
In 2018, he joined the faculty at the University of California, Riverside, becoming the university’s second Nobel Prize winner on the faculty.
Awards and Prizes Nobel Prize in Physics 2017
Elected as Foreign Member to the Royal Society, Great Britain 2019
Elected as Foreign Member of the Academy of Sciences of Spain 2018
Honorary Member: Royal European Academy of Doctors 2018
UC Berkeley – Alumnus of the Year 2018
Fudan-Zhongzhi Science Award – Shanghai, China 2017
Princess of Asturias Prize for Science and Technology – Spain 2017
Giuseppe and Vanna Cocconi Prize; European Physical Society 2017
Henry Draper Medal, National Academy of Sciences 2017
Smithsonian Magazine’s American Ingenuity Award – Physical Sciences 2016
Enrico Fermi Prize; Italian Physical Society 2016
Titan of Physics Award – On the Shoulders of Giants; 2016 World Science Festival NYC
Elected Member, American Academy of Arts and Sciences (AAAS) 2005
Presidential Appointee (Bush), National Science Board (NSB) 2003-2010
Elected Member, National Academy of Science (NAS) 2002
Fellow, American Association for the Advancement of Science (AAAS)
Klopsteg Award for 2002, American Association of Physics Teachers (AAPT)
LIGO 18-34, 1200 E. California Blvd., Pasadena, CA 91125
Fellow, American Physical Society (APS)
Maxine and Ronald Linde Professorship – California Institute of Technology
Honorary Doctoral Degrees
- The University of Sofia, Bulgaria 2018
- Southern Methodist University, Dallas, TX 2018
- University of Glasgow – Glasgow, Scotland 2013
- University of Florida – Gainesville, Florida 2007
- University of Bologna – Bologna, Italy 2006
Research Positions and Major Committees
- AURA LSST Oversight Committee 2016 – present – Chairperson
- Laser Interferometer Gravitational-wave Observatory (LIGO) 1994 – present; Director, LIGO
- Laboratory 1997-2006; Senior Scientist 2006 to present.
- International Linear Collider – Global Design Effort Director 2005 – 2012
- Caltech High Energy Physics Group Principal Investigator 1984-96
- NCR Board of Physics and Astronomy – Neutrino Facilities Assessment Committee
- Chair 2002 Report “Neutrinos & Beyond”
- High Energy Physics Advisory Panel (HEPAP) to DoE and NSF Co-chair of Subpanel a “Long Range Plan for the U.S. High Energy Physics (HEP) program” 2001-2002
- IUPAP U.S. Liaison Committee – Chair 2002-2005
- IUPAP Panel on Nuclear, Particle, and Gravitational-Wave Astrophysics (PaNAGIC) – Member 1998-2005
- IUPAP Commission on Particles and Fields (C-11) 1990-1999
Avologi understands the desire for a non-invasive, at-home, easy-to-use, skin care solution. Thus Avologi continues to innovate and create hand held devices that utilize advanced technologies for anyone who wants to take anti-aging into their own hands.
Avologi products offer cutting-edge, proven and dermatologist recommended solutions for skin rejuvenation to address key beauty concerns that consumers encounter. Our advanced products are based on extensive clinical experience, technological innovation and advance knowhow. Offering unique, non-invasive treatments that initialize advanced age defying technologies to help tighten the appearance of sagging skin and reverse the effects of time for a rejuvenated, younger-looking appearance.
Our mission is to enable consumers to achieve real professional results at the comfort of their own home.
Dr. Randy Schekman is a Professor in the Department of Molecular and Cell Biology, University of California, Berkeley, and an Investigator of the Howard Hughes Medical Institute. He studied the enzymology of DNA replication as a graduate student with Arthur Kornberg at Stanford University. His current interest in cellular membranes developed during a postdoctoral period with S. J. Singer at the University of California, San Diego. Schekman’s laboratory investigates the mechanism of membrane protein traffic in the secretory pathway in eukaryotic cells. In recent years his lab has turned to aspects of vesicular traffic in human cells, most recently on the biogenesis and sorting of small RNAs into extracellular vesicles.
Among his awards are the Gairdner International Award, the Albert Lasker Award in Basic Medical Research and the Nobel Prize in Physiology or Medicine, which he shared with James Rothman and Thomas Südhof. From 2006 – 2011 he served as Editor-in-Chief of the Proceedings of the NAS. In 2011, he founded and until 2019 served as the Editor-in-Chief of the Open Access journal, eLife, sponsored by the HHMI, Wellcome Trust and the Max Planck Society. Beginning in 2018, Schekman assumed a leadership role in an effort supported by the Sergey Brin Family Foundation to identify and support basic research on the mechanisms of Parkinson’s Disease initiation and progression (https://parkinsonsroadmap.org).
Human cells manufacture over 20,000 different proteins which consist of amino acids stitched together to create the many molecules that catalyze and organize cellular processes. Most of these proteins are designed to function within the cell but a significant fraction of them, molecules such as insulin, growth factors and collagen are shipped out by a process called secretion.
This process was poorly understood at the molecular level until work in Schekman lab, using a simple genetic approach with Baker’s yeast, and a biochemical approach using cultured mammalian cells, pioneered in Jim Rothman’s lab, led to the isolation of the genes and proteins that organize the secretory pathway.
A sequence comparison of the genes required for secretion in yeast and the genes that encode proteins required for membrane traffic in mammalian cells showed that the process is conserved over 2B years of evolution. Given this functional conservation, the biotechnology industry exploited yeast as a platform for the production of large quantities of medically important proteins such as recombinant human insulin and the protein used in hepatitis B vaccination. For this work, Schekman and Rothman (along with Thomas Sudhof) shared the 2013 Nobel Prize in Physiology/Medicine.
More recent work has demonstrated that many cells also secrete small membrane carriers called extracellular vesicles (EVs) or exosomes. EVs may carry proteins and RNA to target cells to change the pattern of gene expression or in disease, to promote some pathological process. The Schekman lab now studies EVs assembly, RNA packaging and the effect of isolated EVs on target cell growth and differentiation. In one such study, the lab has found EVs isolated from skin cells (fibroblasts of keratinocytes) stimulate the migration of cells in a wound healing assay.
The hope is that by understanding this process, the vesicles may be used to deliver therapeutic molecules to cells or tissues in humans, e.g. in skin wound healing.
Review by Dr. Stefano Magno
ENEO is a really powerful facial treatment, I really believe that this device is revolutionary in terms of facial treatments.
Dr Magno Stefano - Skin Surgeon
Practicing medicine for more than 25 years
Graduated in Medicine at Catholic University of Rome in 1998, presenting the paper: “Sentinel lymph node biopsy in breast cancer”.
Specialty in general surgery achieved in 2005, presenting the work “Excision margin status and local recurrence in the conservative treatment of breast cancer”.
Since 1995, clinical practice in General Surgery first as student and then as a resident; from 2005 on, surgeon in the Breast Surgery Unit of Catholic University of Rome, particularly focused in clinical and scientific aspects of oncology.
He has performed more than 1.100 surgical interventions (680 as first operator); among them, over 350 breast procedures.
From 1999 to 2006 collaboration with Italian Soccer Federation as physician of National team in the categories under 20 of age
Since 2000, member of the Italian affiliate of a prestigious American non-profit Organization (“Susan G. Komen for the Cure”), focused on breast cancer prevention and treatment.
In february 2002, visiting Resident in the Breast center of “Memorial Sloan Kettering Cancer Center” – New York.
From 2005 to 2008, collaboration with a prestigious scientific Institution (Merck Biochemicals) on the project “Identification of therapeutic targets expressed on breast cancer stem cells”
Completed a three-year universitary course on acupuncture
Member of the Organizing Committee of several International and National Scientific Symposiums
Since 2000, collaboration as teaching professor in a National Educational Program on Breast cancer prevention in Italy, granted by non-profit associations and Italian Government.
Publications:
Crucitti A., La Greca A., Antinori A., Pirulli P., Consiglio F., Magno S., Antonacci V., Masetti R.
“Pancreaticoduodenectomy for pancreatic and periampullary tumors : technical considerations and results” ; “Journal of Surgical Oncology” – Aprile 1999
Masetti R., Antinori A., Pirulli P., Magno S.
Chapter “Mappaggio linfonodale intraoperatorio e biopsia del linfonodo sentinella “ – Bonifacino – Buzdar – Halliwell ; Poletto Editore – 1999.
Masetti R., Antinori A., Pirulli P., Magno S., Zazza S.
Chapter “Chirurgia oncoplastica : radicalità oncologica e cosmesi” – Ottobre 1999 ; Edizioni Idelson-Gnocchi.
R. Masetti, A. Antinori, P.G. Pirulli, S. Magno, F. Chiesa
“Oncoplastic techniques in the conservative surgical treatment of breast cancer”.
Breast Cancer 2000, 7 (4): 276-280.
R. Masetti, G. Franceschini, S. Magno, F. Chiesa
Chapter “La chirurgia oncoplastica della mammella”; Ediz. CLUB -U.E.C. (Pavia): 156-188, 2001
R. Masetti, G. Franceschini, S. Magno, F. Chiesa, R. Pigalarga.
Chapter “DCIS: il chirurgo”- Bari, 121-126; 2002
R.Masetti, G.Franceschini, F.Chiesa, S.Magno, A.Di Leone.
“Oncoplastic surgical techniques in the treatment of breast cancer”. Istanbul Kanser Konferansi Ozet Kitabi. Meme Hast. Derg. 2003; 10(3): 64.
A.Di Leone, S.Magno, F.Chiesa, M.Fabbri, R.Masetti.
“L’intervento chirurgico e l’approccio interdisciplinare nella terapia della neoplasia mammaria”
Atti dell’Accademia Lancisiana, Dicembre 2004
R.Masetti, S.Magno, F.Chiesa, A.Di Leone
“Oncoplastic approaches in the surgical treatment of breast cancer”.
Selected paper (Abstract) – 3th Congress of the World Society for breast health, Aprile 2005
R.Masetti, S.Magno, F.Chiesa, A.Di Leone
“Management of breast cancer in elderly”.
Abstract – 10th Annual Multidisciplinary Symposium on breast disease, Luglio 2005
R.Masetti, A.Di Leone, G.Franceschini, S.Magno, D.Terribile, Maria Cristina Fabbri and F.Chiesa.
“Oncoplastic techniques in the conservative surgical treatment of breast cancer: an overview”.
The Breast Journal 2006, 12 (2): 174-180.
G.Franceschini, D.Terribile, S.Magno, C. Fabbri, P.D’Alba, F.Chiesa, A.Di Leone, R.Masetti.
“Ductal carcinoma in situ. Surgical therapy: a mini review”.
Chirurgia 2007, 20 : 1-3.
G.Franceschini, D.Terribile, C. Fabbri, S.Magno, P.D’Alba, F.Chiesa, A.Di Leone, R.Masetti.
“Management of locally advanced breast cancer”.
Minerva Chirurgica 2007, 62 : 249-255.
G.Franceschini, D.Terribile, S.Magno, C. Fabbri, P.D’Alba, F.Chiesa, A.Di Leone, R.Masetti.
“Update in the treatment of locally advanced breast cancer: a multidisciplinary approach”.
Eur Rev Med Pharmacol Sci 2007, 11(5) : 283-289.
G.Franceschini, D.Terribile, C.Fabbri, S.Magno, P.D’Alba, F.Chiesa, A.Di Leone, R.Masetti.
“Evoluzione nel trattamento chirurgico del carcinoma mammario precoce”.
Annali Italiani di Chirurgia 2008, 79 : 17-22.
G.Franceschini, D.Terribile, S.Magno, C.Fabbri, P.D’Alba, F.Chiesa, A.Di Leone, R.Masetti.
“Conservative treatment of the central breast cancer with nipple-areolar resection: an alternative oncoplastic technique”.
G.Chir 2008, 29 : 23-27.
G.Franceschini, D.Terribile, S.Magno, C.Fabbri, P.D’Alba, F.Chiesa, A.Di Leone, R.Masetti.
“Current controversies in the treatment of ductal carcinoma in situ of the breast”.
Annali Italiani di Chirurgia 2008, 79 .
S.Magno
Chapter: “Le cellule staminali nel carcinoma della mammella” dal libro “Seno buono, seno cattivo”– Edizioni Alpes – Roma, novembre 2008
S.Magno, D.Terribile, G.Franceschini, C.Fabbri, P.D’Alba, F.Chiesa, A.Di Leone, M.Costantini, P.Belli and R.Masetti.
“Breast MRI in a case of “early onset” lactating adenoma”.
The Breast Journal 2009, 15(1): 105-106.
S.Magno, D.Terribile, G.Franceschini, C.Fabbri, P.D’Alba, F.Chiesa, A.Di Leone and R.Masetti.
“Accessory nipple reconstrunction following a central quadrantectomy: a case report”.
Cases Journal 2009, 2 (32).
S.Magno, D.Terribile, G.Franceschini, C.Fabbri, P.D’Alba, F.Chiesa, A.Di Leone, M.Costantini, P.Belli and R.Masetti.
“Early onset lactating adenoma and the role of breast MRI: a case report”.
Journal of Medical Case Reports 2009, 3(43).
G.Franceschini, D.Terribile, I. Scafetta, S.Magno, C.Fabbri, F.Chiesa, A.Di Leone, F.Moschella, A. Mulè and R.Masetti.
“Conservative treatment of a rare case of a multifocale adenoid cystic carcinoma of the breast: case report and literature review”.
Med Sci Monit 2010, 16(3) CS 33-39.
P. Rinaldi, M. Giuliani, P.Belli, M.Costantini, M. Romani, D.Di Stefano, E. Bufi, A.Mulè, S.Magno, R.Masetti and L. Bonomo
“DWI in breast MRI: role of ADC value to determine diagnosis between diagnosis and surgical scar in operated patients”.
Eur J Radiol 2010, 19 Feb
Rinaldi P, Ierardi C, Costantini M, Magno S, Giuliani M, Belli P, Bonomo L.
“Cystic breast lesions: sonographic findings and clinical management”.
Ultrasound Med. 2010, Nov;29(11):1617-26.
Magno S, Nanni L, Retrosi G, Cina A, Gamba PG.
“An Unusual Case of acute Pancreatitis and Gastric Outlet Obstruction Associated with Wandering Spleen Treated by Laparoscopic Splenopexy”.
Laparoendosc Adv Surg Tech 2011, Mar 5.
ABOUT AVOLOGI
Avologi is a luxurious medical beauty brand founded in 2012 by engineers from the Technion Institute. Captivating new intelligence in medical beauty solutions and architects of high-tech, Avologi is derived from professional medical and aesthetic treatments, enabling consumers to achieve professional results at home.
Avologi understands the desire for a non-invasive, at-home, easy-to-use, anti-aging solution, Thus Avologi continues to innovate and create handheld device that utilize advanced technologies for anyone who wants to take anti-aging into their own hands.
The Avologi products offer cutting-edge, proven and dermatologist recommended solutions for skin rejuvenation to address key beauty concerns that customers encounter.
Our mission is to enable consumers to achieve real professional Anti-Aging results in the comfort of their own homes.
OUR VIDEOS
